A M Janson - JoVE Visualize

Showing results (31-40 of 47) with videos related to

Pageof 5

Sort By:

European Heart Journal|May 1, 1987

Evidence for discrete alterations in central cardiovascular catecholamine and neuropeptide Y immunoreactive neurons in aged male rats and in genetically hypertensive male rats of the Lyon strainK Fuxe, L F Agnati, I Kitayama, et al.

Experimental Brain Research|January 1, 1993

Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusionG Chadi, A Møller, L Rosén, et al.

Journal of Neural Transmission|January 1, 1988

Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptamine nerve cell groups of the rostral ventromedial medullaI Kitayama, A M Janson, A Cintra, et al.

Journal of Neural Transmission|January 1, 1987

Effects of acute and chronic treatment with imipramine on 5-hydroxytryptamine nerve cell groups and on bulbospinal 5-hydroxytryptamine/substance P/thyrotropin releasing hormone immunoreactive neurons in the rat. A morphometric and microdensitometric analysisI Kitayama, A M Janson, K Fuxe, et al.

Neuromuscular Disorders : NMD|September 11, 2002

Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophyAnnemieke Aartsma-Rus, Mattie Bremmer-Bout, Anneke A M Janson, et al.

Journal of Neural Transmission|January 1, 1989

Chronic immobilization stress: evidence for decreases of 5-hydroxy-tryptamine immunoreactivity and for increases of glucocorticoid receptor immunoreactivity in various brain regions of the male ratI Kitayama, A Cintra, A M Janson, et al.

Annals of the New York Academy of Sciences|December 6, 2006

Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotidesA Aartsma-Rus, A A M Janson, J A Heemskerk, et al.

American Journal of Human Genetics|December 19, 2003

Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more senseAnnemieke Aartsma-Rus, Anneke A M Janson, Wendy E Kaman, et al.

Gene Therapy|July 2, 2004

Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cellsA Aartsma-Rus, W E Kaman, M Bremmer-Bout, et al.

Oligonucleotides|January 7, 2006

Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sitesAnnemieke Aartsma-Rus, Christa L De Winter, Anneke A M Janson, et al.

Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:

Pageof 5

European Heart Journal|May 1, 1987

Evidence for discrete alterations in central cardiovascular catecholamine and neuropeptide Y immunoreactive neurons in aged male rats and in genetically hypertensive male rats of the Lyon strainK Fuxe, L F Agnati, I Kitayama, et al.

Experimental Brain Research|January 1, 1993

Protective actions of human recombinant basic fibroblast growth factor on MPTP-lesioned nigrostriatal dopamine neurons after intraventricular infusionG Chadi, A Møller, L Rosén, et al.

Journal of Neural Transmission|January 1, 1988

Effects of chronic imipramine treatment on glucocorticoid receptor immunoreactivity in various regions of the rat brain. Evidence for selective increases of glucocorticoid receptor immunoreactivity in the locus coeruleus and in 5-hydroxytryptamine nerve cell groups of the rostral ventromedial medullaI Kitayama, A M Janson, A Cintra, et al.

Journal of Neural Transmission|January 1, 1987

Effects of acute and chronic treatment with imipramine on 5-hydroxytryptamine nerve cell groups and on bulbospinal 5-hydroxytryptamine/substance P/thyrotropin releasing hormone immunoreactive neurons in the rat. A morphometric and microdensitometric analysisI Kitayama, A M Janson, K Fuxe, et al.

Neuromuscular Disorders : NMD|September 11, 2002

Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophyAnnemieke Aartsma-Rus, Mattie Bremmer-Bout, Anneke A M Janson, et al.

Journal of Neural Transmission|January 1, 1989

Chronic immobilization stress: evidence for decreases of 5-hydroxy-tryptamine immunoreactivity and for increases of glucocorticoid receptor immunoreactivity in various brain regions of the male ratI Kitayama, A Cintra, A M Janson, et al.

Annals of the New York Academy of Sciences|December 6, 2006

Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotidesA Aartsma-Rus, A A M Janson, J A Heemskerk, et al.

American Journal of Human Genetics|December 19, 2003

Antisense-induced multiexon skipping for Duchenne muscular dystrophy makes more senseAnnemieke Aartsma-Rus, Anneke A M Janson, Wendy E Kaman, et al.

Gene Therapy|July 2, 2004

Comparative analysis of antisense oligonucleotide analogs for targeted DMD exon 46 skipping in muscle cellsA Aartsma-Rus, W E Kaman, M Bremmer-Bout, et al.

Oligonucleotides|January 7, 2006

Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sitesAnnemieke Aartsma-Rus, Christa L De Winter, Anneke A M Janson, et al.

Pageof 5